Differential inflammasome expression and IL-1 beta secretion in monocyte-derived dendritic cells differentiated with IL-4 or IFN-alpha
Carregando...
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2013
Editora
BIOMED CENTRAL LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
AIDS RESEARCH AND THERAPY, v.10, article ID 35, 5p, 2013
Resumo
Background: NLRP3-inflammasome activation was evaluated in monocyte-derived dendritic cells (DC) obtained through IL-4 (IL4-DC) or IFN-alpha (IFN-DC) protocols and pulsed with chemically inactivated HIV-1. Inflammasome' genes expression and IL-1 beta secretion were compared in DC isolated from 15 healthy subjects (HC) and 10 HIV-1 infected individuals (HIV+). Findings: Whether HIV was able to increased NLRP3-inflammasome genes expression and IL-1 beta secretion in IL4-DC from HC, the induction of inflammasome appeared significantly reduced in IFN-DC from HC, suggesting a different responsive state of IFN-DC compared to IL4-DC. No inflammasome activation was observed in IL4-DC as well as in IFN-DC derived from HIV + subjects, confirming previous findings on ""unresponsive"" state of DC derived from HIV + possibly due to chronic inflammatory state of these individuals. Conclusions: Our results showed that IFN-alpha differently modulates inflammasome expression during monocytes-DC in vitro differentiation. These findings could be of interest considering the on-going research about DC manipulation and therapeutic strategies for HIV + involving DC-based immune-vaccines.
Palavras-chave
Type-1 IFN, Dendritic cells, Inflammasome, NALP3, IL-1 beta, Immunotherapy
Referências
- Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957
- Farkas A, 2011, BRIT J DERMATOL, V165, P247, DOI 10.1111/j.1365-2133.2011.10301.x
- Garcia F, 2011, VACCINE, V29, P6454, DOI 10.1016/j.vaccine.2011.07.043
- Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006
- Korthals M, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-46
- Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579
- Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
- Machmach K, 2012, J VIROL, V86, P4245, DOI 10.1128/JVI.07114-11
- McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674
- Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543
- Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468
- Pontillo A, 2012, AIDS, V26, P11, DOI 10.1097/QAD.0b013e32834d697f
- Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x
- Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
- Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835